[Fall in indirect hemagglutination titer (IHA), indirect immunofluorescence titer (IFA) and immunoglobulin (IgE) during 2 years' therapy with mebendazole in Echinococcus multilocularis of the liver].
D001562:Benzimidazoles / Q000627:therapeutic use*; D004444:Echinococcosis, Hepatic / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005455:Fluorescent Antibody Technique; D006384:Hemagglutination / Q000187:drug effects*; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism*; D008463:Mebendazole / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged
D001562:Benzimidazoles; D007073:Immunoglobulin E; D008463:Mebendazole
Abfall von indirektem Hämagglutinationstiter (IHA), indirektem Immunfluoreszenztiter (IFA) und Immunoglobulin (IgE) unter zweijähriger Therapie mit Mebendazol bei Echinococcus multilocularis der Leber.